December 17, 2010 (Toronto, Canada) — Smokers did not have an enhanced response to clopidogrel compared with nonsmokers in a new analysis of ACS patients in the GRACE registry [1]. The study, ...

WASHINGTON, March 12 (Reuters) - The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug because they do not break it down well, U.S.

LONDON (Reuters) - Patients with heart failure who have had a heart attack but not had artery-clearing angioplasty treatment are less likely to die early if they take Sanofi-Aventis and Bristol-Myers ...

Clopidogrel is a generic prescription oral tablet that’s used to lower the risk of stroke and heart attack in certain adults. The drug is also available as the brand-name drug Plavix. It’s not known ...

The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner. Subscribe to read this story ad ...

Through a new boxed warning, the FDA is alerting healthcare professionals about a subgroup of patients who cannot effectively metabolize the anti-platelet drug Plavix (clopidogrel). These patients, ...

ORLANDO -- The widely used herbal remedy St. John's wort appears to amplify the action of the popular blood-thinning drug clopidogrel, sold as Plavix, a small new clinical study finds. The effect ...

Stent patients who take the blood thinner Plavix along with certain heartburn drugs may face a greater risk of heart attack, stroke and other dangerous events, according to a study released Tuesday.